FINRA's Examination Findings & Priorities
A Look Back & What to Expect in 2018
31 January 2018
The Financial Industry Regulatory Authority (FINRA) recently issued its Report on Examination Findings, as well as its 2018 Regulatory and Examination Priorities Letter. Combined, these two reports provide insight into several broad policy issues that FINRA believes should be key points of emphasis for member firms in 2018. What are these points and how will they affect your business?
In this in-depth webinar, Foley attorneys Dean Jeske, Allison Charney, and Joe Edmondson take a closer look at the following topics:
- A Brief Review of the FINRA360 Initiative: What’s Changed & What Does it Mean?
- Examining FINRA’s 2018 Exam Findings and the Exam Priorities Letter: What’s new? What are the biggest risks?
- Learning the Hidden Nuances That Could Prove Invaluable to Your Exam Preparation.
If you have questions or would like more information, please contact Kayla Huven at [email protected].
Recording
People
Related Insights
April 10, 2026
Energy Current
Mexico Plans to Reactivate Fracking by 2027
President Claudia Sheinbaum announced on April 8 a significant shift in Mexico’s energy policy by unveiling a project to exploit natural…
April 10, 2026
Energy Current
Proposed Legislation Pending in Oklahoma State Legislature Would Impact Responsibility for Payment of Costs Associated with Data Centers and Other Large Load Facilities
Several proposed bills targeting data centers have been proposed in the 2026 session of the Oklahoma State Legislature. Most of these…
April 9, 2026
Health Care Law Today
Hemp Product Use in Medicare: CMS Greenlights Pilot Program under the Substance Access Beneficiary Engagement Incentive
On April 1, 2026, the Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center (CMMI), officially launched a new pilot program which allows participants in specific CMS programs to offer eligible hemp products to eligible Medicare beneficiaries.